The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing ...

RNA-based liquid biopsy developed at the University of Chicago detects early-stage colorectal cancer with 95% accuracy using ...

Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require ...

Getting a liquid biopsy is a simple blood draw for breast cancer patients like your mother. Depending on the type of cancer and her treatment, it’s possible additional liquid biopsies may be ...

A blood test that can be administered in the first trimester of pregnancy identified women at risk for developing preeclampsia 5 months before symptom onset, data show. Researchers said the test — a ...

The Global Liquid Biopsy Market was valued at $4,072.6 Mn in 2023 & is expected to reach $20,224.7 Mn by 2033, growing at a CAGR of 16.83% during the forecast 2024-2033.

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

A liquid biopsy is a blood test that more and more oncologists are using to help detect and treat lung cancer. Learn about the different types and what they do.

A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...